ライフサイエンスコーパス: Enterococcus faecium

1 rfusions, including 3 Candida species and an Enterococcus faecium .

2 ectrum activity against vancomycin-resistant Enterococcus faecium.

3 s aureas and vancomycin-resistant strains of Enterococcus faecium.

4 requently precedes invasive infection due to Enterococcus faecium.

5 and vancomycin, such as vancomycin-resistant Enterococcus faecium.

6 isolated from 29 cultures, all of which were Enterococcus faecium.

7 has been identified in nonstool isolates of Enterococcus faecium.

8 plasmid identified in a clinical isolate of Enterococcus faecium.

9 coccus aureus, Streptococcus pneumoniae, and Enterococcus faecium.

10 trols expression of vancomycin resistance in Enterococcus faecium.

11 e of 24% and all isolates were identified as Enterococcus faecium.

12 ncoding VanB-type glycopeptide resistance in Enterococcus faecium.

13 gene fusion is regulated by VanR and VanS of Enterococcus faecium.

14 ent bacteremia as a result of infection with Enterococcus faecium.

15 of chaperonin from a Gram-positive organism, Enterococcus faecium.

16 eroxide produced by the pathogenic bacterium Enterococcus faecium.

17 gens, including Clostridioides difficile and Enterococcus faecium.

18 tobacter baumannii, and vancomycin-resistant Enterococcus faecium.

19 hylococcus aureus, Enterococcus faecalis and Enterococcus faecium.

20 ted promising antibacterial activity against Enterococcus faecium.

21 patients were Clostridium sp. 7 2 43FAA and Enterococcus faecium.

22 of the bacteria such as Escherichia coli and Enterococcus faecium.

23 idermidis in synthetic urine also containing Enterococcus faecium.

24 aphylococcus aureus and vancomycin-resistant Enterococcus faecium.

25 s Lactococcus casei, Lactococcus lactis, and Enterococcus faecium.

26 neonate colonized with vancomycin-resistant Enterococcus faecium.

27 aphylococcus aureus and vancomycin-resistant Enterococcus faecium.

28 rmediate S. aureus, and vancomycin-resistant Enterococcus faecium.

29 due to rESKAPE strains (vancomycin-resistant Enterococcus faecium [0], methicillin-resistant Staphylo

30 cocci (16.9%), Escherichia coli (11.8%), and Enterococcus faecium (11.4%).

31 Enterococcus faecalis (48%), Enterococcus faecium (14%), Enterococcus mundtii (13%),

32 ates of Enterococcus faecalis, 8 isolates of Enterococcus faecium, 2 isolates of Enterococcus hirae,

33 single-patient VRE isolates that included 83 Enterococcus faecium, 33 E. gallinarum, and 5 E. casseli

34 us faecalis (87/91 isolates and ATCC 19433), Enterococcus faecium (5/13 isolates), Enterococcus casse

35 Enterococcus faecium 664.1H1 is multiply antibiotic resi

36 hich contain the vancomycin-binding site) in Enterococcus faecium, a leading antibiotic-resistant pat

37 etyltransferases are nanomolar inhibitors of Enterococcus faecium AAC(6')-Ii.

38 ined individually and in combination against Enterococcus faecium, Acinetobacter baumannii and Klebsi

39 A collagen-binding adhesin of Enterococcus faecium, Acm, was identified.

40 rcent of bacteria were MDR, including 95% of Enterococcus faecium and 55% of Enterobacteriaceae; 82%

41 periments for commensal gut bacteria species Enterococcus faecium and Akkermansia muciniphila in hund

42 , Bacteroides fragilis, and a combination of Enterococcus faecium and Bacteroides distasonis.

43 stant microbes, such as vancomycin-resistant Enterococcus faecium and carbapenem-resistant Klebsiella

44 ted with mutated genes was disparate between Enterococcus faecium and E. faecalis index and persisten

45 cover and differentiate vancomycin-resistant Enterococcus faecium and Enterococcus faecalis (VRE).

46 al for high-level glycopeptide resistance in Enterococcus faecium and Enterococcus faecalis by synthe

47 rogen sources to support their growth, where Enterococcus faecium and Enterococcus faecalis have some

48 utomated methods that test susceptibility of Enterococcus faecium and Enterococcus faecalis to beta-l

49 aphylococcus epidermidis and vanA or vanB in Enterococcus faecium and Enterococcus faecalis) by the B

50 bacteria, including human pathogens such as Enterococcus faecium and Listeria monocytogenes.

51 ia (high priority) were vancomycin-resistant Enterococcus faecium and meticillin-resistant Staphyloco

52 against Gram-positive Enterococcus faecalis, Enterococcus faecium and multidrug resistant (MDR) Staph

53 With the exception of 2 isolates, Enterococcus faecium and Nocardia exalbida, all the othe

54 e, including elevated relative abundances of Enterococcus faecium and Staphylococcus aureus.

55 drug-sensitive and drug-resistant strains of Enterococcus faecium and Staphylococcus aureus.

56 vast majority of E. faecalis strains (unlike Enterococcus faecium and streptococci) have a single pil

57 strains of three novel sequence types, three Enterococcus faecium and two Enterococcus durans.

58 The VRE type A strain was a vanA strain of Enterococcus faecium and was highly resistant to all ant

59 occus pneumoniae, Enterococcus faecalis, and Enterococcus faecium) and three associated genetic resis

60 ptomycin versus 48 Enterococcus faecalis, 51 Enterococcus faecium, and 50 Staphylococcus aureus isola

61 Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and beta-lactam-resistant Klebsiel

62 t Staphylococcus aureus, vancomycinresistant Enterococcus faecium, and bioweapon Bacillus anthracis.

63 domonas aeruginosa, Acinetobacter baumannii, Enterococcus faecium, and Candida auris.

64 Staphylococcus aureus, Helicobacter pylori, Enterococcus faecium, and Enterobacter spp.

65 single polypeptide in Enterococcus faecalis, Enterococcus faecium, and Enterococcus hirae.

66 aureus, high-level vancomycin resistance in Enterococcus faecium, and resistance to extended-spectru

67 that the silver/platinum combination against Enterococcus faecium, and silver/copper combination agai

68 ted and dispersed MRSA, vancomycin-resistant Enterococcus faecium, and Staphylococcus epidermidis bio

69 Two species, Enterococcus faecalis and Enterococcus faecium, are common constituents of the hum

70 in the cell walls of vancomycin-susceptible Enterococcus faecium (ATTC 49624).

71 ied 14/15 cases of Enterococcus faecalis and Enterococcus faecium bacteremia and 9 cases of Streptoco

72 ront-line antibiotic for multidrug-resistant Enterococcus faecium bloodstream infections (BSIs).

73 level type A and B vancomycin resistances of Enterococcus faecium BM4147 and Ent. faecalis have been

74 d-alanine-d-lactate ligase from Enterococcus faecium BM4147 is directly responsible for

75 igh-level inducible vancomycin resistance in Enterococcus faecium BM4147.

76 sistance has been reported for an isolate of Enterococcus faecium, BM4339.

77 or secreted antigen, SagA, was identified in Enterococcus faecium by screening an E. faecium genomic

78 tion by ampicillin- and vancomycin-resistant Enterococcus faecium C68 in a mouse model.

79 estinal colonization by vancomycin-resistant Enterococcus faecium C68 in a mouse model.

80 The plasmids pHKK702 and pHKK703 from Enterococcus faecium clinical isolate R7 have been impli

81 tide resistance element, Tn1546, in 124 VanA Enterococcus faecium clinical isolates from 13 Michigan

82 serologically related, vancomycin-resistant Enterococcus faecium clinical isolates.

83 We identify Acinetobacter baumannii and Enterococcus faecium co-association on multiple surfaces

84 The opportunistic pathogen Enterococcus faecium colonizes humans and a wide range o

85 87 specimens that were culture positive for Enterococcus faecium containing vanA were positive by PC

86 nd ponA) were deleted from the chromosome of Enterococcus faecium D344R in all possible combinations

87 the excision of a large genomic region from Enterococcus faecium D344R in which the sequence from "j

88 ur in ampicillin-resistant, Tn916-containing Enterococcus faecium D344R.

89 tems of esp-deficient Lactococcus lactis and Enterococcus faecium did not enhance biofilm formation a

90 We discovered that Enterococcus faecium (E. faecium), a ubiquitous commensa

91 Here, we identified 2 gene clusters in Enterococcus faecium each encoding a homolog of Gls24 (G

92 ted REG3 proteins that mediated depletion of Enterococcus faecium (Efm) from the gut microbiota.

93 Enterococcus faecium encodes a triple-specific aaPGS (Ra

94 identification of VanA- and VanB-containing Enterococcus faecium (ENFM) and Enterococcus faecalis (E

95 r Acinetobacter baumannii, Escherichia coli, Enterococcus faecium, Enterococcus faecalis, Klebsiella

96 infections caused by Staphylococcus aureus, Enterococcus faecium, Enterococcus faecalis, Klebsiella

97 nterococci, including Enterococcus faecalis, Enterococcus faecium, Enterococcus gallinaraum, and Ente

98 rophosphate LTAs from Enterococcus faecalis, Enterococcus faecium, Enterococcus hirae, Listeria monoc

99 rast to previously characterized aaPGSs, the Enterococcus faecium enzyme used an expanded repertoire

100 Enterococcus faecium, Escherichia coli, and Enterococcus

101 es (Bacillus subtilis, Campylobacter jejuni, Enterococcus faecium, Escherichia coli, Legionella pneum

102 Strains of Enterococcus faecium express a cell wall-anchored protei

103 g a predicted fibronectin-binding protein of Enterococcus faecium (fnm), a homologue of Streptococcus

104 s in tissues of morphine-withdrawn mice were Enterococcus faecium followed by Klebsiella pneumoniae.

105 pplemental testing of ampicillin-susceptible Enterococcus faecium for motility and the ability to aci

106 mained febrile and grew vancomycin-resistant Enterococcus faecium from the cerebrospinal fluid.

107 omonas aeruginosa, Staphylococcus aureus, or Enterococcus faecium) from 1 January 2012 through 30 Dec

108 We tested this idea in a mouse model of Enterococcus faecium gastrointestinal tract colonization

109 The Enterococcus faecium genogroup, referred to as clonal co

110 of antibiotic resistance determination from Enterococcus faecium genomes for diagnosis and surveilla

111 edicting antimicrobial resistance (AMR) from Enterococcus faecium genomics data, offering excellent p

112 nosocomial isolation of multidrug-resistant Enterococcus faecium has dramatically reduced the therap

113 Enterococcus faecium has recently emerged as a serious n

114 Enterococcus faecium has recently emerged as an importan

115 An enzyme that remodels the cell wall of Enterococcus faecium helps these gut bacteria to divide

116 In Enterococcus faecium, high levels of resistance to beta-

117 The incidence of multidrug-resistant Enterococcus faecium hospital infections has been steadi

118 e focus on the important nosocomial pathogen Enterococcus faecium in a hospital system where resistan

119 rted to be important for the pathogenesis of Enterococcus faecium in a rat infective endocarditis mod

120 nfection following exposure to nonpathogenic Enterococcus faecium in the nematode Caenorhabditis eleg

121 l activity against Enterococcus faecalis and Enterococcus faecium in vitro, and characterise this act

122 istant bacteria such as vancomycin-resistant Enterococcus faecium in vitro.

123 Enterococcus faecalis and Enterococcus faecium infections are increasingly difficu

124 In particular, vancomycin-resistant Enterococcus faecium infections have been increasing in

125 y tract infections; and vancomycin-resistant Enterococcus faecium infections, including cases with co

126 99 for the treatment of vancomycin-resistant Enterococcus faecium infections.

127 nized cluster of 10 genetically related VRE (Enterococcus faecium) infections was discovered.

128 Enterococcus faecium is a common cause of nosocomial inf

129 lthough the opportunistic bacterial pathogen Enterococcus faecium is a leading source of nosocomial i

130 Enterococcus faecium is a microbiota species in humans t

131 Enterococcus faecium is a multidrug-resistant opportunis

132 Enterococcus faecium is an important cause of hospital-a

133 nical settings, non-susceptibility to DAP by Enterococcus faecium is correlated frequently with a mut

134 We show that secreted antigen A (SagA) from Enterococcus faecium is sufficient to protect Caenorhabd

135 estinal colonization by antibiotic-resistant Enterococcus faecium is the first step in a process that

136 ble to vancomycin, with the exception of one Enterococcus faecium isolate (1/450, 0.2%).

137 report of vancomycin heteroresistance in an Enterococcus faecium isolate from a patient.

138 Enterococcus faecalis (50) outnumbered Enterococcus faecium isolates (18), and 49% of enterococ

139 containing SmaI restriction patterns from 62 Enterococcus faecium isolates and the other containing S

140 The genomic relationships among Enterococcus faecium isolates are the subject of ongoing

141 clinical isolates of glycopeptide-resistant Enterococcus faecium isolates collected from hospitals i

142 lso detect npmA2 in two vancomycin-resistant Enterococcus faecium isolates from a Dutch hospital.

143 e streptogramin quinupristin-dalfopristin in Enterococcus faecium isolates from chickens on the Easte

144 us, 90% of Enterococcus faecalis, and 88% of Enterococcus faecium isolates were interpreted as suscep

145 All Enterococcus faecalis and Enterococcus faecium isolates were observed to be nonmot

146 inezolid-resistant Enterococcus faecalis and Enterococcus faecium isolates with a G2576U rRNA mutatio

147 The increasing frequency of Enterococcus faecium isolates with multidrug resistance

148 tibiotic-resistant Staphylococcus aureus and Enterococcus faecium isolates, than methylenomycins A an

149 E are present in most E. faecalis but not in Enterococcus faecium isolates.

150 he E. faecalis isolates and six (23%) of the Enterococcus faecium isolates.

151 Clostridioides difficile, Escherichia coli, Enterococcus faecium, Klebsiella pneumoniae, Neisseria g

152 ii, Escherichia coli, Enterococcus faecalis, Enterococcus faecium, Klebsiella pneumoniae, Pseudomonas

153 eus, Bacillus cereus, Enterococcus faecalis, Enterococcus faecium, Listeria monocytogenes, Streptococ

154 reaks of linezolid- and vancomycin-resistant Enterococcus faecium (LR-VRE) in solid organ transplant

155 th seed hydrolysates after fermentation with Enterococcus faecium-LR9 and to compare it with Leuconos

156 of linezolid-resistant, vancomycin-resistant Enterococcus faecium (LRVRE).

157 Enterococcus faecalis (green colonies) from Enterococcus faecium (mauve colonies) on the basis of ch

158 as antibiotics against vancomycin-resistant Enterococcus faecium, methicillin-resistant Staphylococc

159 dynamic modeling that bisected the wild-type Enterococcus faecium MIC distribution.

160 +/- 0.4 microg/mL), and vancomycin-resistant Enterococcus faecium (MIC(50) 2.9 +/- 0.8 microg/mL).

161 beum (Staphylococcus aureus: MIC: 16 mug/mL; Enterococcus faecium: MIC: 32 mug/mL) and Harungana mada

162 The high-level-resistant strain (Enterococcus faecium; MIC, 512 microg/ml) was accurately

163 stream infection caused by a DAP-susceptible Enterococcus faecium (minimum inhibitory concentration,

164 pneumoniae (n = 12), P. aeruginosa (n = 11), Enterococcus faecium (n = 10), and Staphylococcus aureus

165 Isolated species included Enterococcus faecium (n = 13), Enterococcus faecalis (n

166 esistant Staphylococcus aureus (n = 14), and Enterococcus faecium (n = 14).

167 ine and linezolid were highly active against Enterococcus faecium (n = 267) globally (100% and 98% su

168 ee important pathogens: vancomycin-resistant Enterococcus faecium (n=19), methicillin-resistant Staph

169 n of the vanA gene in 81 cultures containing Enterococcus faecium or E. faecalis was 100% sensitive a

170 The four patients presented here had either Enterococcus faecium or Enterococcus faecalis bacteremia

171 Oral reintroduction of Enterococcus faecium or Enterococcus faecalis restores a

172 ated colonies as either vancomycin-resistant Enterococcus faecium or Enterococcus faecalis, based on

173 ylococcus aureus, but not Bacillus subtilis, Enterococcus faecium, or Streptococcus pyogenes, kill ad

174 or nearly identical strains of the pathogen Enterococcus faecium, or the gut commensals Akkermansia

175 Enterococcus faecium organisms (MIC, > 256 micrograms/ml

176 By organism, Campylobacter jejuni and Enterococcus faecium phenotypes were more robustly predi

177 ation demonstrated platinum and gold against Enterococcus faecium, platinum against Klebsiella pneumo

178 t the cryo-electron microscopy structures of Enterococcus faecium PolC bound to DNA and in complex wi

179 Here, we identify and characterize 6 Enterococcus faecium proteins containing the WxL domain

180 Previously, we have shown that 2 Enterococcus faecium proteins, the secreted antigen A an

181 ne quinupristin-dalfopristin (Q-D)-resistant Enterococcus faecium (QDREF) isolates were isolated from

182 Enterococcus faecium recently evolved from a generally a

183 in-resistant enterococci (VRE), particularly Enterococcus faecium, represent a significant nosocomial

184 The past few years have seen Enterococcus faecium resistance to vancomycin increase f

185 annii and several other important pathogens (Enterococcus faecium, S. aureus, Klebsiella pneumoniae,

186 We have shown previously that Enterococcus faecium SagA has broad-spectrum binding to

187 enterococcal isolates were tested, including Enterococcus faecium (six isolates), Enterococcus faecal

188 Human epidemic clones ( E. coli ST131 and Enterococcus faecium ST17) were identified for the first

189 ptococcus pneumoniae, Enterococcus faecalis, Enterococcus faecium, Staphylococcus aureus, and Klebsie

190 and gram positives Clostridioides difficile, Enterococcus faecium, Staphylococcus aureus, and Strepto

191 he rapid identification of ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella

192 Mortality was also analyzed for Enterococcus faecium, Staphylococcus aureus, Klebsiella

193 isms such as the ESKAPEE pathogens (includes Enterococcus faecium, Staphylococcus aureus, Klebsiella

194 The ESKAPE pathogens - Enterococcus faecium, Staphylococcus aureus, Klebsiella

195 We also report that most Enterococcus faecium, Staphylococcus aureus, Klebsiella

196 rug-resistant organisms (MDROs), and ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella

197 identifies the most common ESKAPE bacteria (Enterococcus faecium, Staphylococcus aureus, Klebsiella

198 p, Enterococcus spp., Enterococcus faecalis, Enterococcus faecium, Staphylococcus spp., Staphylococcu

199 ted to be efficacious against a DAP-tolerant Enterococcus faecium strain (HOU503).

200 Enterococcus faecium strain 9631355 was isolated from an

201 One-on-one comparisons of 10 vanA Enterococcus faecium strain types all yielded > 10 band

202 An Enterococcus faecium strain with high-level resistance t

203 re induced in one Campylobacter coli and one Enterococcus faecium strain, while these strains plus th

204 of patients were infected with the same vanB Enterococcus faecium strain.

205 lled two (28%) of seven vancomycin-resistant Enterococcus faecium strains.

206 ; however, smaller segments were detected in Enterococcus faecium strains.

207 ridans streptococcus, Enterococcus faecalis, Enterococcus faecium, Streptococcus agalactiae, Escheric

208 taphylococcus aureus, Enterococcus faecalis, Enterococcus faecium, Streptococcus pyogenes, Streptococ

209 n-resistant Staphylococcus aureus (MRSA) and Enterococcus faecium, surpassing several licensed antibi

210 utational study of RseP from EntK1-sensitive Enterococcus faecium to identify regions of RseP involve

211 quired resistance of the nosocomial pathogen Enterococcus faecium to the group A component of natural

212 For one strain (Enterococcus faecium U8304), the ability of GPS to detec

213 in a clinical strain of daptomycin-resistant Enterococcus faecium, using a murine model of peritoniti

214 ococcus pneumoniae (6), vancomycin-resistant Enterococcus faecium (VRE FCM) (16), vancomycin-suscepti

215 rointestinal tract with vancomycin-resistant Enterococcus faecium (VRE) has become endemic in many ho

216 A mouse model of vancomycin-resistant Enterococcus faecium (VRE) intestinal colonization was u

217 Vancomycin-resistant Enterococcus faecium (VRE) is a leading cause of hospita

218 Vancomycin-resistant Enterococcus faecium (VRE) is a major cause of nosocomia

219 c DNA extracted from 45 vancomycin-resistant Enterococcus faecium (VRE) isolates was cleaved with Hin

220 ical data for typing 45 vancomycin-resistant Enterococcus faecium (VRE) isolates.

221 Thirty-two isolates of vancomycin-resistant Enterococcus faecium (VRE) recovered from 25 patients ho

222 tion rule to guide anti-vancomycin-resistant Enterococcus faecium (VRE) therapy.

223 onization of the gut by vancomycin-resistant Enterococcus faecium (VRE), a leading cause of hospital-

224 lococcus aureus (MRSA), vancomycin-resistant Enterococcus faecium (VRE), and beta-lactam-resistant Kl

225 lococcus aureus (MRSA), vancomycin-resistant Enterococcus faecium (VRE), Escherichia coli SMS-3-5, an

226 to marked expansion of vancomycin-resistant Enterococcus faecium (VRE), Klebsiella pneumoniae, and E

227 te the dissemination of vancomycin-resistant Enterococcus faecium (VREF) in a 728-bed tertiary-care h

228 Vancomycin-resistant Enterococcus faecium (VREF) was isolated from six pigs b

229 occus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VREF) with MIC values of 1.4 and 2

230 occus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VREF).

231 the nosocomial pathogen vancomycin-resistant Enterococcus faecium (VREfm) can lead to bloodstream inf

232 population structure of vancomycin-resistant Enterococcus faecium (VREfm) in Latin America (LATAM).

233 Vancomycin-resistant Enterococcus faecium (VREfm) is a leading cause of healt

234 Vancomycin-resistant Enterococcus faecium (VREfm) is a leading cause of nosoc

235 Vancomycin-resistant Enterococcus faecium (VREfm) is an important cause of he

236 ion and transmission of vancomycin-resistant Enterococcus faecium (VREfm) is the driver for E. faeciu

237 nt organisms, including vancomycin-resistant Enterococcus faecium (VREfm).

238 ncomycin-resistant Enterococcus faecalis and Enterococcus faecium, VRESelect, was compared to bile es

239 o-component signal transduction pathway from Enterococcus faecium was reconstituted in vitro from par

240 precedes infection with antibiotic-resistant Enterococcus faecium We used a mouse GIT colonization mo

241 When 10(3) or 10(6) cfu/mL of VR Enterococcus faecium were added to the CFCE culture, the

242 etworks centered around Escherichia coli and Enterococcus faecium were analyzed.

243 ates of E. faecalis and 24 blood isolates of Enterococcus faecium were compared.

244 cocci [IVRE]) from Enterococcus faecalis and Enterococcus faecium were evaluated.

245 f the 8 bacteria (Pseudomonas aeruginosa and Enterococcus faecium were the exception) and are project

246 These effects do not occur in Enterococcus faecium, which lacks the respiratory chain

247 Virginiamycin use in poultry selects for Enterococcus faecium with cross-resistance to quinuprist

248 experimental endocarditis using a strain of Enterococcus faecium with high-level resistance to vanco

249 ly, pretreatment of Staphylococcus aureus or Enterococcus faecium with subinhibitory doses of beta-la

250 Two isolates of Enterococcus faecium with VanA glycopeptide resistance w

251 luyvera georgiana , Klebsiella oxytoca , and Enterococcus faecium , with lower levels of short-chain

252 experiments to investigate the transport of Enterococcus faecium within saturated quartz sands.

253 lactis ZGBP5-51, Enterococcus faecium ZGBP5-52 and Enterococcus faecalis